Twist Bioscience Corporation stock is up 65.5% since 30 days ago. The next earnings date is Feb 2, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 December’s closed higher than November. In the last 6 Unusual Options Trades, there were 6 PUTs.
|Date & Time||Expiration Date||Strike Price||Trade Type||Size||Open Interest|
|25 Oct 16:15||15 Dec, 2023||15.00||175|
|17 Nov 17:49||19 Apr, 2024||35.00||517|
|17 Nov 18:34||19 Apr, 2024||35.00||517|
|24 Nov 15:28||19 Apr, 2024||35.00||907|
|27 Nov 17:50||19 Apr, 2024||35.00||1202|
|08 Dec 20:10||19 Jul, 2024||20.00||0|
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium.